• English
  • 简体中文
Login Register
Current Location: Home > WHO Drug Information Feedback Help
Type Title Date Posted Read more
International Nonproprietary N Proposed INN: List 119 WHO Drug Information,2018,32,2 view
ATC/DDD classification ATC/DDD classification (final) WHO Drug Information,2018,32,2 view
ATC/DDD classification ATC/DDD classification (temporary) WHO Drug Information,2018,32,2 view
Consultation documents Other recent WHO consultation documents WHO Drug Information,2018,32,2 view
Consultation documents Proposal for revision of the WHO Certification Scheme on the Quality of Pharmaceutical Products Moving inInternational Commerce WHO Drug Information,2018,32,2 view
Consultation documents Inquiry regarding production of water for injections WHO Drug Information,2018,32,2 view
Consultation documents Polymorphism WHO Drug Information,2018,32,2 view
Consultation documents Daclatasvir tablets(Daclatasviri compressi) WHO Drug Information,2018,32,2 view
Consultation documents Daclatasvir dihydrochloride(Daclatasviri dihydrochloridum) WHO Drug Information,2018,32,2 view
Consultation documents Atazanavir capsules(Atazanaviri capsulae) WHO Drug Information,2018,32,2 view
Consultation documents Atazanavir sulfate(Atazanaviri sulfas) WHO Drug Information,2018,32,2 view
Publications and events Joint UNFPA-UNICEF-WHO meeting WHO Drug Information,2018,32,2 view
Publications and events 18th International Conference of Drug Regulatory Authorities (ICDRA) WHO Drug Information,2018,32,2 view
Publications and events 78th FIP World Congress of Pharmacy and Pharmaceutical Sciences WHO Drug Information,2018,32,2 view
Publications and events WHO-UMC-HSA Inter-Regional Pharmacovigilance Training workshop WHO Drug Information,2018,32,2 view
Publications and events Pakistan joins collaborative registration WHO Drug Information,2018,32,2 view
Publications and events Additional medicines invited WHO Drug Information,2018,32,2 view
Publications and events “Firsts” WHO Drug Information,2018,32,2 view
Publications and events New WHO stability guideline published WHO Drug Information,2018,32,2 view
Publications and events WHO prequalification updatesICH Q3D introduced for APIs WHO Drug Information,2018,32,2 view